What is...The FDA today announced the approval of Atryn for hereditary antithrombin deficiency and also announced that since Atryn, being a protein, is not really a drug and is so close chemically to naturally occuring ATIII, that it doesn't need to undergo further testing and approval for all the multitude of uses that studies have proven AtIII to be beneficial for?
Market Data 
Markets 
AI
